US$ 29.48
1 mg bpc 157 daily bpc-157 clinical trials dosage BPC-157 Dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or BPC-157 Dosage Calculator and Chart
Description
This preservative action allows the vial to be accessed repeatedly over a designated periodtypically up to 28 daysbefore it must be safely discarded

But it is not just them

Cycle length 8 to 12 weeks on, 4 to 6 weeks off in common research community protocols

Pueden falsear analtica en la medicin de la B12 srica
